Seeing Is Believing
Currently out of the existing stock ratings of Daniel Brims, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).
Analyst Daniel Brims works at HC WAINWRIGHT with a stock forecast success ratio of 66.67% fulfilled within 39.33 days on average. Previously, Daniel Brims worked at HCWAINWRIGHT.
Daniel Brims’s has documented 17 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TTPH, Tetraphase Pharmaceuticals at 08-Sep-2015.
Analyst best performing recommendations are on TTPH (TETRAPHASE PHARMACEUTICALS).
The best stock recommendation documented was for TTPH (TETRAPHASE PHARMACEUTICALS) at 9/9/2015. The price target of $220 was fulfilled within 9 days with a profit of $30.2 (15.91%) receiving and performance score of 17.68.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
3 years 11 months 24 days ago
1/2 (50%)
$36.05 (72.09%)
304
Buy
140
4 years 7 months 29 days ago
0/4 (0%)
$69.6 (98.86%)
Buy
380
4 years 11 months 22 days ago
0/3 (0%)
$224.8 (144.85%)
Buy
5 years 7 months 12 days ago
0/3 (0%)
$150.4 (116.05%)
Buy
140
$137.8 (6263.64%)
120
5 years 8 months 3 days ago
0/3 (0%)
$81.4 (104.62%)
What Year was the first public recommendation made by Daniel Brims?